NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

$2.48
As of 06/24/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/01/2014
Outstanding shares:  42,721,566
Average volume:  459,128
Market cap:   $105,095,052
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    603380106
ISIN:        US6033801068
Sedol:      BNB7PK5
Valuation   (See tab for details)
PE ratio:   7.46
PB ratio:   2.32
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy